BioCentury
ARTICLE | Clinical News

Orencia abatacept: Phase II data

June 23, 2008 7:00 AM UTC

Data from 50 evaluable patients with inflammatory arthritis in a double-blind, Phase II trial showed that 12 of 26 patients receiving Orencia developed RA at 1 year vs. 16 of 24 patients receiving pla...